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 1
INTRODUCTION 
 
                                                    
Neonatal and perinatal mortality rates are the major indicators for the 
health status of the nation. In developed countries, the neonatal and 
perinatal mortality rates are 3–5 and 8–9 per 1000 live births respectively[1,2]. 
In India, despite remarkable progress in urban areas   neonatal and  perinatal  
mortality rates are  still high.   
 
    The current neonatal mortality rate (NMR) in India is 44 per 1000 live 
births (rural and urban being 46.7/1000 and 31.7 /1000 respectively)[3]. 
Many studies reveal that nearly  half  (32-52%)  of  this  is due to  respiratory  
distress  in  neonatal  period[4,5]. Respiratory distress is one of the 
commonest problems of newborn  occurring throughout the world ( 3-7%  
of all live births)[5-8].  
 
                  In cases of respiratory distress -- adequate and immediate 
resuscitation, oxygen supplementation, maintenance of optimal temperature, 
timely referral and optimal ventilatory support will reduce the mortality.    
                                      
Assisted ventilation is one of the important methods in the 
management of respiratory distress in neonates. It is an acute, short term 
intervention to support the physical process of respiration partially or 
completely till the newborn is able to breathe again unassisted.                                                
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There are two basic types of assisted ventilation.         
 
 
1. Invasive ventilation 
 
2. Non-Invasive ventilation 
 
 
Invasive ventilation (although potentially lifesaving) is one of the 
more expensive therapies in neonatal intensive care. And it   is not free of 
associated morbidity (higher incidence of bronchopulmonary dysplasia and 
retinopathy of prematurity in preterm infants and more chance for 
infection). It requires highly skilled medical personnel to operate and 
monitor the baby with frequent blood sampling (e.g.-ABG monitoring). 
Another expensive item other than the equipment is nursing and respiratory 
practitioner labour cost which varies from place to place.  
  
  Gentle Non-Invasive ventilation like Bubble CPAP has many 
advantages.   Bubble CPAP is relatively simple and inexpensive. With 
pulseoximeter monitoring, these neonates can be effectively managed[9]. The 
long term morbidity  is also less in Bubble CPAP, without any significant 
difference in mortality (Avery et al-1987)[10]. With trained persons it can be 
used in all secondary   level hospitals to serve the purpose of large number 
of neonates in developing countries like India[11,12 ]. This sort of low cost  
interventions are the most cost effective method to reduce morbidity and 
mortality.  
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REVIEW OF LITERATURE 
                                        
 
RESPIRATORY DISTRESS  
                                                        
 
As per the recommendations of National Neonatology Forum 
India[13 ]   incidence  of  respiratory distress   and   subsequent perinatal 
mortality can be reduced by  improved  prenatal care, early detection , 
referral of high risk pregnancies, closer links between  referral hospitals and 
health centers,  close monitoring of labour to detect fetal distress and  early 
intervention when indicated.  
 
The usual manifestations of respiratory distress in neonates are 
tachypnea, retractions, grunting. Central cyanosis, lethargy and poor feeding. 
Various scoring systems are available to assess the severity of respiratory 
distress clinically. We used DOWNES SCORE to assess respiratory distress. 
 
DOWNES SCORE 
 
 
 0 1 2 
Cyanosis None In room air In 40% FIO2 
Retractions None Mild Severe 
Grunting None 
Audible with 
stethoscope 
Audible without 
stethoscope 
Air entry Clear Decreased or delayed Barely audible 
Respiratory rate Under 60 60-80 Over 80 or  apnea 
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CAUSES OF RESPIRATORY DISTRESS  
 
 
The common medical conditions in India 
[ 14]
 
 
1. Transient tachypnea of newborn  (TTN)   
 
2. Perinatal  asphyxia  
 
3. Respiratory distress syndrome (RDS)  
 
4. Meconium aspiration  syndrome (MAS)  
 
5. Bronchopneumonia - sepsis 
 
6. Aspiration  
 
7. Pulmonary hypertension 
 
8. Cardiac disorders  
 
9. Neurologic disorders 
 
10.  Metabolic problems. 
 
 
Surgical conditions include  
 
1. Choanal atresia 
 
2. Pneumothorax  
 
3. Diaphragmatic hernia  
 
4. Tracheo - esophageal fistula  
 
5. Pierre Robin Syndrome (upper airway obstruction due to  
glossoptosis) 
 
6. Congenital Lobar emphysema. 
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DISADVANTAGES OF INVASIVE VENTILATION IN 
RESPIRATORY  
 
DISTRESS 
 
Conventional mechanical ventilation via an endotracheal tube has 
undoubtedly led to improvement in neonatal survival. However the 
prolonged use of an endotracheal tube and mechanical ventilation may cause 
 
1. Upper airway damage 
2. Altered mucociliary flow 
3. Nosocomial infection   
4. Broncho Pulmonary Dysplasia 
5. Volutrauma 
6. Barotrauma 
7. End-expiratory alveolar collapse 
  
ADVANTAGES  OF  NON-INVASIVE VENTILATION IN 
RESPIRATORY  
 
DISTRESS 
 
Continuous Positive Airway Pressure is a method of delivering 
Positive  End–Expiratory Pressure with a variable amount of oxygen to the 
airway of a spontaneously breathing  neonate to maintain lung volume 
during expiration so as to reduce atelectasis and to improve 
oxygenation[15,16,17].  CPAP splints the chest, maintains end-expiratory 
volume (FRC) [18,19,20].  It supports the respiratory muscles which are at risk 
of fatigue. (Muller et al.)      
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HISTORY 
                    
             CPAP was first used in 1971 to support breathing of preterm 
neonates.  The first reported use of CPAP for the treatment of HMD was 
by Gregory et al. in 1971. In the seventies, Dr. Jen-Tien Wung at the 
Columbian Presbyterian Medical Center, New York developed the Bubble 
CPAP system using short nasal prongs[21].  In 1987, Avery et al published a 
retrospective study of 1625   neonates at eight tertiary centers[22].  In that 
study, Columbia University where the predominant mode of respiratory 
support was nasal CPAP, had the lowest incidence of chronic lung disease 
(CLD) without any significant difference in mortality. 
 
         Even in the pre- surfactant era and when antenatal steroid usage was 
uncommon, there was some evidence that early application of CPAP might 
reduce subsequent use of mechanical ventilation and   the associated adverse 
outcome. Infants extubated to nasal CPAP experienced a reduction in 
respiratory failure necessitating assisted   reventilation. 
    
BENEFITS OF CPAP
[23]
  
 
1. Reduces upper airway occlusion by decreasing upper airway resistance 
and increasing the pharyngeal cross sectional area. 
2. Reduces right to left shunting. 
3. Reduces obstructive apneas. 
4. Increases the FRC. 
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5. Reduces inspiratory resistance by dilating the airways. This permits a 
larger tidal volume for a given pressure, thereby reducing the work of 
breathing. 
6. Increases the compliance and tidal volume of stiff lungs with a low 
FRC by stabilizing the chest wall and counteracting the paradoxical 
movements.  
7. Regularizes and slows the respiratory rate. 
8. Reduces the incidence of apnea. 
9. Increases the mean airway pressure and improves ventilation 
perfusion mismatch.  
10. Conserves surfactant. 
11. Diminishes alveolar edema. 
12. Nasal CPAP after extubation reduces the proportion of babies 
requiring re-ventilation. 
13. Oxygenation is related to the surface area of alveoli and carbon 
dioxide elimination is related to the minute volume. Normalizing lung 
volume improves both oxygenation and carbon dioxide elimination.  
  
Fundamentally, the delivery of continuous positive airway pressure 
requires three components: 
1. Flow generation  
2. An airway interface  
3. A positive pressure system. 
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FLOW GENERATION 
 
Two major varieties exist - Constant flow and Variable flow.  The 
flow generator usually also warms and humidifies the inhaled gases. 
Constant flow is usually provided by an infant ventilator which can be used 
in two ways. Most often, the amount of flow is set by the clinical team.  
                                         
Alternatively, variable flow devices use a dedicated flow generator. 
Here the expiratory limb of the circuit is open to the atmosphere and the 
infant can draw extra gas from this limb to support inspiratory efforts. This 
device has gained widespread acceptance in Europe and North America.  
Despite the theoretical advantages of the variable flow device, there are no 
consistent data showing clinical long-term meaningful benefit over constant 
flow devices. 
 
AIRWAY INTERFACE 
 
Arrays of airway interfaces are in use:  
 
single prongs 
binasal prongs (short & long) 
nasopharyngeal prongs 
endotracheal tubes 
head boxes 
pressurized plastic bags 
nasal cannulae and face masks.  
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Nasal prongs are very easy to apply and non-invasive to the airways. 
The infant can still be nursed and handled with uninterrupted CPAP. A 
Cochrane Systematic Review suggests that short binasal prongs are more 
effective in preterm infants at preventing re-intubation compared to single 
nasal prongs. Nasal prongs can however cause nasal excoriation and 
scarring[24,25,26].   
 
Short nasal prongs (Fisher & Paykel) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
POSITIVE PRESSURE SYSTEM – can be of three types 
 
1. The expiratory valve of the ventilator is used to adjust the expiratory 
pressure.  
2. The pressure is generated by adjusting the inspiratory flow or altering   
the expiratory resistance. 
3. The Bubble CPAP system produces a positive pressure by placing the 
far end of the expiratory tubing under water. The pressure is adjusted 
by altering the depth of the tube under the surface of the water.   
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BUBBLE CPAP 
 
Essentially, the bubble CPAP system consists of three components: 
  
1. A continuous gas flow into the circuit 
2. An  expiratory limb with the distal  end submerged into a liquid   to 
generate positive end  expiratory pressure  
3. Nasal interface connecting the infant's airway with the circuit.                                
 
 
As the gas leaves the circuit via the expiratory limb, it bubbles.           
Oxygen blender connected to wall oxygen and compressed air supply is used 
for supplying appropriate concentration of inspired oxygen[27,28,29].  
 
Optimal gas flow is maintained with a flow meter to prevent 
rebreathing of carbon dioxide, increased work of   breathing related to 
insufficient flow available for inspiration and to compensate for leakage   in 
the CPAP system. Flow rate of 5 to 10 liters per minute is optimal for 
CPAP delivery in the neonates[30,31].   
 
BUBBLE CPAP 
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OXYGEN FLOW GENERATOR WITH BLENDER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pressure in the bubble CPAP system is created by placing the distal 
expiratory tubing in water. Designated pressure is determined by the length 
of expiratory limb being immersed. When the pressure is delivered to the 
baby without leakage, it results in continuous bubbling and the pressure 
oscillates in the circuit. Leakage is not obvious in ventilator CPAP. Though 
the pressure oscillation was once suggested to facilitate gas exchange, this 
postulation was not supported in another recent report[32,33].  
 
CPAP is now used for a variety of neonatal conditions. It is effective 
in supporting the recently extubated infant and for treating apnea of 
prematurity. Increasingly, it is also seen as an alternative to intubation and 
ventilation in the treatment of HMD. Coupling CPAP with short duration 
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intubation and early delivery of a single dose of surfactant for moderate to 
severe HMD, improves oxygenation and reduces the need for mechanical 
ventilation[34,35]. This approach is known as the INSURE technique 
(Intubation, Surfactant administration, Rapid Extubation).  
            
MONITORING: 
 
The use of CPAP requires proper attention to the infant’s airway. 
Both the correct prong size and proper positioning of the infant’s neck are 
needed to avoid excessive flexion or extension. Optimal humidification of 
the inhaled gas should be ensured and the airway requires frequent suction 
to clear accumulated secretions.   An oral gastric tube will help to relieve 
gaseous distension of the bowel.  
 
Robertson et al., demonstrated in a cohort of infants requiring CPAP, 
20% had nasal complications - columella necrosis, flaring of the nostrils and 
snubbing of the nose. Observation and care of the nasal area is important in 
the nursing care of infants requiring nasal CPAP. Clinicians should be aware 
that CPAP has been associated with more serious complications including 
pneumothorax and air embolism[37,38]. Therefore all infants needing 
respiratory support be it, invasive or non-invasive continue to require 
careful monitoring for clinical deterioration. No compromises for CPAP 
should be made in this regard, and CPAP usage requires constant 
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observation of breathing patterns and standardized and rigorous training of 
physicians, respiratory practitioners and nursing staff.  
NURSING CARE 
 
Elaborate nursing care is pivotal for the success for Bubble CPAP.  
Proper positioning of the prongs can be secured by putting an appropriate 
size hat which rests along the lower part of the infant's ears and across his 
forehead with the circuit fastened on it. It has to be snugly fitted and 
stationed on the infant's head. Otherwise the circuit and the prong will 
move with the motion of the loosely fit hat. Tissue necrosis was observed if 
one was unable to keep the prong in the nostrils of an active infant.  
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Nasal trauma is common when the prong rests on the septum of the 
nose or on the columella. Proper application   can   prevent the accidental 
incarceration of the prong onto the nasal septum or the columella 
.Moreover adequate airway humidification and    gentle nasal suctioning is   
paramount in maintaining a clear airway without jeopardizing the tissue 
integrity of the nostrils. 
 
The probe and chamber temperature and the positioning of the 
temperature probe can be manipulated to minimize the "rain-out".  
Consistent bubbling is important to recruit alveoli, maintain functional 
residual capacity and reduce airway resistance and work of breathing 
especially in the early acute phase of respiratory distress. If the bubbling 
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stops it means that there is a pressure leak in the system, usually around the 
nostrils. It has been reported that the pharyngeal pressure drops markedly 
when the CPAP supported infant opens his mouth. Recent study 
demonstrated that, the prong pressure though not totally transmitted to the 
pharynx was more effectively transmitted when the mouth was closed. The 
use of chin strap or pacifier has been recommended to reduce mouth leak 
for effective CPAP support. However it should not be so tight as to prevent 
the infant from yawning or crying but tight enough to prevent leaking at 
rest.  The infant's respiratory status has to be assessed at regular interval to 
evaluate effectiveness of the treatment and plan for subsequent care. CPAP 
has to be temporarily interrupted during chest auscultation as the bubbling 
sounds may interfere. 
 
However, caution has to be taken as the infant may   present with 
apnea and bradycardia when CPAP support is suspended for just a brief   
period.  Gastric distension is common in the CPAP supported infant (CPAP 
Belly Syndrome).  Frequent decompression of the stomach with an oro-
gastric tube is necessary to promote comfort, preventing the distended 
stomach from splinting the diaphragm and compromising the respiration.   
 
DEVELOPING WORLD AND CPAP 
 
        Many infants, with higher mortality and morbidity, are denied access 
to neonatal intensive care in the developing world because scarce financial 
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resources are directed towards more viable infants. In a prospective study 
from South Africa, Pieper et al. conducted a randomized control trial of 
CPAP for infants, birth weight 775 - 1160 gm who were denied access to 
NICU. When compared with the standard therapy of head box oxygen these 
babies treated with CPAP had better outcome. 
 
Although the CPAP was initially placed by respiratory therapists, the 
ongoing care was continued by nursing staff with no intensive care or CPAP 
experience. The infants who received CPAP in these circumstances had a 
significantly improved short term survival (at 24 hours), with trends towards 
improved long-term survival[39].   
  
SETTING UP A CPAP SYSTEM 
 
      The simplest and least expensive nasal CPAP system, to set up, is the 
Bubble CPAP system . One requires the equipment shown in  Table. 
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Equipment for CPAP 
 
Container with lid, filled with sterile water (or 0.25% acetic acid) to a 
depth of 10 cm  H2O. 
Column to fit through the lid of this container with graduated scale 
from 0-10 cm  H2O. 
Oxygen source, flow meter with blender, analyzer and oxygen tubing. 
Inspiratory and expiratory circuits. 
Manometer. 
Heater and humidifier. 
Nasal prongs with bonnet. 
  
  
Fill the container with sterile water to 10 cm H2O and place the 
container below the level of the infant. The column should be fitted into the 
container through the lid and placed under the fluid level to desired pressure 
i.e., initially 4-6cm H2O; the expiratory circuit from the infant is connected 
to the column. The expiratory circuit will need a port and pressure tubing 
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leading to a calibrated manometer. Snug fitting short, anatomical nasal 
prongs are secured with a bonnet and the inspiratory circuit is connected to 
the oxygen supply, flow meter, blender and analyzer via a humidified heater. 
A starting flow of 6L per min should be used, increasing to produce a steady 
stream of bubbles in the water container. The column can then be lowered 
or raised to the desired pressure to ensure steady bubbling. 
 
General Indications for CPAP  
 
1. Spontaneously breathing babies with respiratory distress at birth. 
2. Increased work of breathing indicated by: recession, grunting, nasal 
flaring, increased oxygen requirements or increased  respiratory rate. 
3. Poorly expanded or infiltrated lung fields on chest x-ray. 
4. Atelectasis. 
5. Pulmonary edema. 
6. Pulmonary hemorrhage. 
7. Apnea of prematurity. 
8. Recent extubation. 
9. Tracheomalacia or other abnormalities of the airways, predisposing to 
airway collapse. 
10. Phrenic nerve palsy. 
 
Contraindications to CPAP 
 
1. Upper airway abnormalities (cleft palate, choanal atresia). 
2. Tracheo-esophageal fistula. 
3. Diaphragmatic hernia. 
4. Severe cardiovascular instability. 
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OBJECTIVE 
 
AIM:  
             
The objective is to study the outcome of non-invasive ventilation 
using  Bubble  CPAP  in neonates with respiratory distress in Newborn 
Unit, Chengalpattu Medical  College Hospital, Chengalpattu. 
 
 
STUDY PERIOD 
 
      The study was conducted in Newborn Unit, Chengalpattu Medical 
College from January 2008 to June 2008 – (6 months period)   
 
SUBJECTS  
 
INCLUSION CRITERIA  
 
Neonates admitted in Newborn Unit with respiratory distress 
 
1. Down score  4 - 6   
2. Oxygen saturation SPO2 < 85% even with supplemental oxygen 
included in the study. 
 
EXCLUSION CRITERIA 
 
Babies with 
 
  1.  Severe respiratory distress (score > 7/10), 
  2.  Unstable cardiovascular status,  
3. Prolonged & refractory seizures  
4. Major congenital anomalies including upper airway anomalies, 
pulmonary hypoplasia diaphragmatic hernia, etc,.   
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MATERIALS AND METHODS 
                    
During the six months period of January 2008 to June 2008,   
neonates admitted in our Newborn Unit with respiratory distress were 
included in this prospective study. All neonates with respiratory distress 
were given routine initial care and stabilized. Respiratory distress was 
diagnosed if any of the two of the following were present (NNF) 
 
i. Respiratory rate > 60/min during quiet breathing  
ii. Inspiratory retractions of chest  
iii. Expiratory grunting.     
 
Severity of respiratory distress was assessed by using DOWNES 
SCORE. Babies with total score < 4 were managed with Oxygen via hood at 
a rate of 6-8 liters/minute. If the distress increased they were started on 
Bubble CPAP. Babies with total score > 6 were intubated and given 
mechanical ventilation. If the distress decreased (score = 4-6) they were 
weaned to Bubble CPAP. Babies having initial total score between 4 – 6, 
were put on Bubble CPAP directly. If the distress increased they were 
intubated and started on mechanical ventilation. If the distress decreased 
they were weaned to oxygen gradually.      
 
Investigations to diagnose the cause of respiratory distress were done 
including radiograph of the chest in all cases. Expert opinion was obtained 
from the radiologist. Blood sample was collected under sterile conditions 
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and sent for analysis (Complete Blood Count, micro ESR, peripheral smear 
study, Glucose, Urea, Creatinine, Calcium, other electrolytes, Culture & 
Sensitivity etc.). Blood pressure was monitored with a non-invasive blood 
pressure monitor. Hypotension (mean BP < 30 mm Hg) was corrected with 
plasma expanders and dopamine drip as and when indicated.  The sensor of 
a pulse oximeter was placed around the foot to continuously monitor the 
SPO2 and heart rate and it was shielded from light and heat.  
 
Indications for shifting to CPAP ventilation were,             
 
(i) Downe score  4 – 6 
(ii) Oxygen saturation SPO2 < 85% even with supplemental oxygen  
 
A   Bubble CPAP   system   (Fisher & Paykel) was used to deliver 
CPAP through short nasal prongs placed in both anterior nares and secured 
firmly with a cotton tape tied around the head. The nasal prongs were 
checked for any displacement regularly and for blockage due to secretions 
every 4 hours.  
 
Initial CPAP Settings : 
 
(i) FiO2 :  0.6  to  0.8 
(ii) Flow  rate : 5 to 10 liter/minute  
(iii) CPAP: 4 to 6 cm water with increment of 2 cm at a time, up to a 
maximum of 10 cm of water to achieve SPO2 of 85 to 90%.   
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  All the infants recruited in the study were followed till discharge or 
death.  Duration of CPAP, course of the illness, changing of treatment 
modalities from CPAP to IMV, weaning from IMV to CPAP, weaning 
from CPAP to oxygen and complications of CPAP were meticulously 
documented. 
 
Following outcomes were taken into account. 
 
- Weaned from CPAP and discharged 
- CPAP failure 
- Mortality in the study population. 
 
WEANING :  
 
When SPO2 reached 90% or more the FiO2   was lowered in 
decrements of 0.05 to maintain   a SPO2 of > 85%. When the FiO2 could 
be lowered to 0.5 or less CPAP was reduced in decrements of 2 cm of 
water. The nasal prongs were removed when the CPAP was < 3 cm of 
water at FiO2 < 0.4.  
 
CPAP FAILURE  -  was defined as  
 
• Persistent  SPO2 of < 85% and/or  rising Downes score over 6 
• Recurrent apneic spells or poor respiratory effort.  
 
The efficacy of CPAP ventilation was analyzed in different weight   
groups.  The success being defined as persistent SPO2 > 85% and survival. 
CPAP failures were shifted to IPPV. Infants on IPPV were monitored by 
pulse oximetry. 
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RESULTS AND DISCUSSION 
 
 
Out of the 2812 babies born at our hospital during the 6 months 
study period, 102 (3.6%) babies were admitted to the neonatal intensive care 
unit (NICU) for respiratory distress. 18 cases were excluded from the study 
due to various reasons like severe respiratory distress, unstable 
cardiovascular status, refractory seizures during admission. Four babies in 
the study group were delivered at home. 9 babies in the study group were 
delivered at nearby government hospitals and referred here for management 
of respiratory distress. Three babies in the study group were delivered in 
private hospital.  There were 39 males and 61 females in the study group. 
16% babies in the study were delivered by caesarian section.  
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OUTCOME 
 
 
In our study out of 100 neonates with respiratory distress 74 babies 
weaned from CPAP ventilation and discharged. 26 babies succumbed to the 
illness. Mortality was high in babies weighing < 1.5 kg, and babies with 
sepsis.  
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SEX WISE DISTRIBUTION 
 
Male - 39 
 
Female - 61 
 
 
39%
61%
male
female
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 27
 
 
 
SEX WISE SURVIVAL 
 
 
Out of 39 male babies 27 (69 %) survived 
 
Out of 61 females 47 (77%) survived 
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BIRTH WEIGHT WISE DISTRIBUTION 
 
 
Wt < 1.5 kg = 22 babies.  Out of these 16 babies (72%) survived. 
Wt > 1.5 kg = 78 babies. Out of these 68 babies (87%) survived.  
 
The mean birth weight of the babies under study was 2217 gm (800-
4000 gm). The overall prognosis of babies weighing more than 1500 gm was 
good with survival of 87%. Survival of babies in the weight group <1500 gm 
was 27%.                            .  
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SURVIVAL IN TERM & PRETERM BABIES 
 
Out of 34 Preterm babies 27 babies (79%) survived 
Out of 51 Term AGA babies 37 babies (72%) survived 
Out of 15 Term IUGR babies 10 babies (66%) survived   
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DOWNES SCORE ON DAY- 0 
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DOWNES SCORE ON DAY-3 
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CYANOSIS SCORE ON DAY- 0 AND DAY- 3 
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GRUNTING SCORE ON DAY-0 AND DAY-3 
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RESPIRATORY SCORE ON DAY- 0 AND DAY - 3 
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AIR ENTRY SCORE ON DAY- 0 AND DAY - 3 
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CHEST RETRACTION SCORE ON DAY- 0 AND DAY - 3   
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STATISTICAL ANALYSIS 
 
 
T test cy0=cy3 
 
Paired t test 
 
-------------------------------------------------------------------------------------------- 
Variable |     Obs       Mean    Std. Err.    Std. Dev.   [95% Conf. Interval] 
-----------+------------------------------------------------------------------------------- 
     cy0    |     100         .91      .0287623    .2876235    .8529293    .9670707 
     cy3    |     100         .32      .0583961    .5839607    .2041295    .4358705 
-----------+------------------------------------------------------------------------------- 
    diff      |     100         .59      .0621094    .6210939    .4667615    .7132385 
-------------------------------------------------------------------------------------------- 
 
Ho: mean (cy0 - cy3) = mean (diff) = 0 
       Ha: mean (diff) < 0            Ha: mean (diff) ~= 0       Ha: mean(diff) > 0 
        t =   9.4994                 t =   9.4994               t =   9.4994 
    P < t =   1.0000           P > |t| =   0.0000           P > t =   0.0000 
 
T test rr0=rr3 
Paired t test 
---------------------------------------------------------------------------------------------- 
Variable |     Obs     Mean       Std. Err.     Std. Dev.   [95% Conf. Interval] 
-----------+--------------------------------------------------------------------------------- 
     rr0     |      99           2               0                 0                 2               2 
     rr3     |      99    .7070707    .0899535    .8950262    .5285609    .8855805 
-----------+--------------------------------------------------------------------------------- 
    diff        |      99    1.292929    .0899535    .8950262    1.114419    1.471439 
---------------------------------------------------------------------------------------------- 
 
Ho: mean (rr0 - rr3) = mean(diff) = 0 
        Ha: mean (diff) < 0         Ha: mean (diff) ~= 0         Ha: mean(diff) >0 
        t = 14.3733                 t = 14.3733              t = 14.3733 
    P < t =   1.0000           P > |t| =   0.0000           P > t =   0.0000 
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T test gr0=gr3 
 
Paired t test 
 
---------------------------------------------------------------------------------------------- 
Variable  |     Obs    Mean    Std. Err.   Std. Dev.     [95% Conf. Interval] 
-----------+--------------------------------------------------------------------------------- 
     gr0    |     100         .99         .01          .1      .9701578    1.009842 
     gr3    |     100         .51    .0834787    .8347866     .3443602    .6756398 
-----------+--------------------------------------------------------------------------------- 
    diff     |     100         .48    .0834605    .8346051     .3143962    .6456038 
--------------------------------------------------------------------------------------------- 
 
Ho: mean (gr0 - gr3) = mean (diff) = 0 
 
       Ha: mean (diff) < 0        Ha: mean (diff) ~= 0        Ha: mean (diff) > 0 
        t = 5.7512                 t = 5.7512                t = 5.7512 
    P < t = 1.0000           P > |t| = 0.0000           P > t = 0.0000 
 
T test air0=air3 
 
Paired t test 
 
------------------------------------------------------------------------------------------- 
Variable  |     Obs      Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
-----------+------------------------------------------------------------------------------ 
    air0        |     100         .95    .0219043    .2190429    .9065371    .9934629 
    air3         |     100         .54    .0869459    .8694594    .3674804    .7125196 
-----------+------------------------------------------------------------------------------ 
    diff        |     100         .41    .0888706    .8887058    .2336615    .5863385 
------------------------------------------------------------------------------------------- 
 
Ho: mean (air0 - air3) = mean (diff) = 0 
 
    Ha: mean (diff) < 0     Ha: mean (diff) ~= 0     Ha: mean (diff) > 0 
        t = 4.6135                    t = 4.6135               t = 4.6135 
    P < t = 1.0000             P > |t| = 0.0000        P > t = 0.0000 
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T test re0 = re3 
 
Paired t test 
 
--------------------------------------------------------------------------------------------- 
Variable    |     Obs     Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
-----------+------------------------------------------------------------------------------- 
     re0     |     100        1.15    .0411329    .4113295    1.068383    1.231617 
     re3     |     100         .49     .073161      .7316095    .3448328    .6351672 
-----------+------------------------------------------------------------------------------- 
    diff     |     100         .66     .0806789    .8067894    .4999155    .8200845 
-------------------------------------------------------------------------------------------- 
 
Ho: mean (re0 - re3) = mean (diff) = 0 
 
     Ha: mean (diff) < 0          Ha: mean (diff) ~= 0        Ha: mean (diff) > 0 
        t = 8.1806                 t = 8.1806                t = 8.1806 
    P < t = 1.0000           P > |t| = 0.0000           P > t = 0.0000 
 
T test tot0=tot3 
 
Paired t test 
 
------------------------------------------------------------------------------------------- 
Variable |     Obs     Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
----------+------------------------------------------------------------------------------- 
    tot0   |     100           6     .0586033    .5860327    5.883718    6.116282 
    tot3   |     100        2.46    .3610926    3.610926    1.743514    3.176486 
----------+------------------------------------------------------------------------------ 
    diff    |     100        3.54    .3577201    3.577201    2.830206    4.249794 
------------------------------------------------------------------------------------------ 
 
Ho: mean (tot0 - tot3) = mean (diff) = 0 
 
     Ha: mean (diff) < 0          Ha: mean (diff) ~= 0         Ha: mean (diff) > 0 
        t = 9.8960                 t = 9.8960                t = 9.8960 
    P < t = 1.0000           P > |t|= 0.0000           P > t = 0.0000 
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T test tot3, by (dead1) 
 
Two-sample t test with equal variances 
 
---------------------------------------------------------------------------------------------- 
   Group   |     Obs     Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
------------+-------------------------------------------------------------------------------- 
      0        |      74    .6351351    .1977046     1.70072    .2411104     1.02916 
       1        |      26    7.653846    .4504436    2.296821     6.72614    8.581552 
------------+-------------------------------------------------------------------------------- 
combined |     100         2.46    .3610926    3.610926    1.743514    3.176486 
------------+-------------------------------------------------------------------------------- 
    diff       |           -7.018711    .4265329                    -7.865152    -6.17227 
---------------------------------------------------------------------------------------------- 
 
Degrees of freedom: 98 
 
Ho: mean (0) – mean (1) = diff = 0 
 
           Ha: diff < 0               Ha: diff ~= 0              Ha: diff > 0 
     t = -16.4553                t = -16.4553               t = -16.4553 
    P < t =   0.0000          P > |t| =   0.0000      P > t =   1.0000 
 
logistic dead1 tot3 age sex bwt  
no observations 
r(2000); 
 
logistic dead1 tot3 age sex1 bwt 
 
Logit estimates                                    Number of obs    =        100 
                                                    LR chi2(4)       =       78.84 
                                                    Prob > chi2      =      0.0000 
Log likelihood = -17.885725                Pseudo R2      = 0.6879 
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------------------------------------------------------------------------------------------- 
  dead1 | OddsRatio   Std. Err.       z       P>|z|    [95% Conf. Interval] 
---------+-------------------------------------------------------------------------------- 
    tot3  |   2.128297   .3029425      5.306   0.000       1.610171    2.813148 
     age  |   1.824714   1.598525      0.687   0.492       .3277229    10.15975 
    sex1 |   .4002889   .4075939     -0.899   0.369       .0544049    2.945161 
     bwt |   .5493918   .2931049     -1.123   0.262       .1930898    1.563165 
------------------------------------------------------------------------------------------- 
 
        
CYANOSIS 
 
 
Variable Observed Mean Std. error Std. deviation 
Score – day 0 100 0.91 0.0287 0.287 
Score – day 3 100 0.32 0.0583 0.583 
Difference 100 0.59 0.0621 0.621 
 
 
 
RESPIRATORY RATE 
 
 
Variable Observed Mean Std. error Std. deviation 
Score – day 0 100 2 0 0 
Score – day 3 100 0.707 0.0899 0.895 
Difference 100 1.29 0.0899 0.895 
 
 42
GRUNTING 
 
Variable Observed Mean Std. error Std. deviation 
Score – day 0 100 0.99 0.01 0.1 
Score – day 3 100 0.51 0.0834 0.8347 
Difference 100 0.48 0.0834 0.8346 
 
 
AIR ENTRY 
 
Variable Observed Mean Std. error Std. deviation 
Score – day 0 100 0.95 0.0219 0.219 
Score – day 3 100 0.54 0.0869 0.869 
Difference 100 0.41 0.0888 0.888 
 
 
RESPIRATORY EFFORT 
 
Variable Observed Mean Std. error Std. deviation 
Score – day 0 100 1.15 0.0411 0.411 
Score – day 3 100 0.49 0.0731 0.731 
Difference 100 0.66 0.0806 0.806 
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TOTAL SCORE 
 
 
Variable Observed Mean 
Std. 
error 
Std. 
deviation 
Downes score – day 0 100 6 0.0586 0.5860 
Downes  score – day 3 100 2.46 0.3610 3.610 
Difference 100 3.54 0.3577 3.577 
 
 
 
OUTCOME OF BUBBLE CPAP VENTILATION 
 
 
 
GROUP Observed Mean Std. error 
Std. 
deviation 
0 74 0.6351 0.1977 1.700 
1 26 7.6538 0.4504 2.296 
Combined 100 2.46 0.3610 3.610 
Difference 100 0.59 0.4265 4.265 
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   In this study there was significant improvement of respiratory 
distress in the babies treated Bubble CPAP.   All parameters like – cyanosis, 
grunting, tachypnea, chest indrawing and air entry improved with Bubble 
CPAP administration.   There was significant reduction of mortality in 
babies with respiratory distress   while using Bubble CPAP. (P <0.0001)  
 
  The mean duration of CPAP administered in this study was 28 hours 
(range 6-72 hours).  Among the 30 CPAP failures, 21 failed within the first 
24 hrs. While 9 did well for the first 24 hours   they failed to maintain the 
desired SaO2 and had to be shifted to IPPV after 24 hrs. Among these 9 
babies, four improved and weaned to CPAP again after 24 to 48 hrs.  
 
Various causes of respiratory distress and their outcome observed in this 
study were, 
 
1. Perinatal Asphyxia = total 53 babies. Out of these 40 babies (75%) 
survived.   
2. Preterm – RDS = total 32 babies. Out of these 27 babies (84%) 
survived  
3. Preterm- Apnea of prematurity – 2 babies. Both babies (100%) were 
weaned from CPAP. 
4. MAS = total 7 babies. Out of these 4  babies (57%)  survived 
5. Bronchopneumonia – Sepsis = total 6 babies. Out of these 3 babies 
(50%) survived      
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Out of this, 16 babies with RDS and all babies with MAS & Sepsis 
had significant radiological findings.     
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Various studies have stated that, CPAP is useful in the treatment of 
RDS with survival rates of 67-83%. In our study 27 (84%) of the 32 
neonates with RDS survived on CPAP. We treated 7 infants of MAS with 
CPAP ventilation, of which 4 (59%) survived. The distending pressure of 
CPAP directly stimulates the pulmonary stretch receptors increasing the  
ventilatory  drive.   Infants suffering from septicemia had high mortality, 
with only 3 of the 6 cases treated surviving, however, the cause of death in 
such cases is multifactorial.   
 
Overall neonatal mortality due to respiratory distress had come down 
in our Newborn unit after using Bubble CPAP. Neonatal mortality due to 
respiratory distress was 45% prior to the use of Bubble CPAP. After using 
Bubble CPAP, neonatal mortality due to respiratory distress was 28% only.     
 
COMPLICATIONS 
 
    
There were few complications of nasal CPAP in our study.  
Displacement of the nasal prongs was a very common   problem whereas 
blockage due to secretions occurred rarely. Displacement of nasal prongs 
was quite troublesome and required dedicated staff to replace it frequently. 
However, this has to be seen in comparison with the expertise required for  
intubation, the problems of keeping it free of secretions and its long-  term 
complications.  
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Mild ulcerations of nasal mucosa occurred in 4 (4%) infants  that 
healed without scarring. Six babies (6%) developed gastric distension which 
subsided within 24 hrs. Transient hypotension noted in 2 babies which was 
corrected with fluid bolus.     
 
Pneumothorax didn’t occur. None had the complications of oxygen 
toxicity. CPAP failures faired poorly on IPPV also, irrespective of their 
weight. There   was no incidence of skin injury or burn due to   the probe of 
the pulse oximeter.   
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CONCLUSION 
 
 
 
Considering that inexpensive CPAP resuscitators and pulse oximeters 
are now   available, we conclude that, this form of therapy should   be 
adopted even by the smaller hospitals to improve the survival of neonates 
with respiratory distress. 
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SUMMARY & RECOMMENDATIONS 
 
 
 Most of our level-2 hospitals treat respiratory distress in   newborns 
with oxygen alone and accept high mortality and morbidity. Establishing a 
NICU in smaller hospitals with equipment, expertise and staffing for IPPV 
and ABG analysis is neither economically viable practical.  
 
  
Although ABG monitoring has distinct advantages, it requires 
considerable expertise, is invasive and not easily available. Conversely, pulse- 
oximetry not only monitors oxygen saturation of hemoglobin continuously 
but is also simple and noninvasive. We found nasal CPAP ventilation 
complemented with pulse -oximetry, a simple and efficient method for 
treating neonates with respiratory distress.  
 
      Concerns about the damaging effects, and expense, of conventional 
mechanical ventilation have led neonatologists to seek new methods of 
respiratory support for the preterm infant such as non-invasive respiratory 
support.  Non-invasive pressure support is useful because it can limit lung 
injury namely Volutrauma, 
 
Barotrauma and Atelectotrauma. CPAP maintains FRC, recruitment, 
decreases upper airway collapse and promotes the release and conservation 
of surfactant.  
 50
 
CPAP is effective in preventing extubation failure and also in the 
management of apnea of prematurity. The low cost of CPAP systems 
coupled with a standardized training for physicians and nursing staff, may be 
of benefit in the developing world with finite finances for supporting 
newborn babies with respiratory distress.  
 
 
         Even though Bubble CPAP is less costly when compared to 
mechanical ventilator the cost could still be reduced by making it with 
indigenous products for the benefit of our community.  Many multicentric 
trials have to be done in this regard for the benefit of the community at 
large.     
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MODEL PROFORMA 
 
Name: ………………………………… Age: …………   Sex:  M / F 
IP No:………………………………….. DOB:……………………… 
Place:  ChMCH / GH / PHC/ NH / Home 
Mode: LN / Breech / Forceps / LSCS     (Indication:                           )   
B.WT:   >4  /  > 2.5 /  1.5  -   2.5 /  < 1.5 
Term / Preterm:    AGA / SGA / LGA:      Gestational Age :      
Apgar:1mt :      5 mt:         10 mt: 
 
MATERNAL DETAILS  
Name : ……………………….……… Age :          G:     P:    L:    A:       
LMP :              EDD :                  Blood Gp :          MRO / PROM : 
Antenatal steroids :  Y / N    Received Antibiotics : Y / N     Other risk 
factors: HT/ DM/   
 
NICU DETAILS 
DOA:                                        
Indication for Admission :   Diagnosis on Admission : 
O/E: Colour – pink/ acro cyanosis/ central cyanosis :      
cry & activity  :               HR :   > 100 / mt  (or)   < 100 / mt:          
RR :         Resp.  Distress:   Y / N:         SpO:                  CRT :  
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DOWNES SCORE 
 
CVS :                  RS :                       ABDOMEN ;                             CNS :  
 
(INVESTIGATIONS) :  X – Ray   chest  :                        others:        
 
Treatment :    
 
 
Outcome :          
 
 
MECHANICAL  VENTILATION : 
 
Indications for  ventilation : apnea / ^ wob / desat / failed CPAP / 
hypoventilation / shock                                                   
 
Sedation :  yes  /  no : Size  of ETT tube : 2.5/ 3/ 3.5/ 4   :  Depth  :      
      
Date of intubation :                         Date of extubation :  
 
 
 
 
 
 0 1 2 
Cyanosis None In room air In 40% FIO2 
Retractions None Mild Severe 
Grunting None 
Audible with 
stethoscope 
Audible without 
stethoscope 
Air entry Clear 
Decreased or 
delayed 
Barely audible 
Respiratory rate Under 60 60-80 Over 80 or  apnea 
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Date & 
time 
Mode FiO2 PIP PEEP Rate SpO2 HR BP 
Perfu
sion 
Drugs 
given 
Remarks 
            
            
            
            
            
 
Complications during ventilation: tube block/ Acc. Extubation/ aspiration/ 
pneumothorax/ pulm. hge/ VAP/  
                                 
Post  extubation  status :       normal /  cpap  /  reintubation  /  stridor  /  
other  complications 
 
Outcome :  
 
NASAL  CPAP : 
 
Indications for CPAP :                                           Size  of  nasal  prongs :                        
Date & 
time 
FiO
2 
CPAP Flow SpO2 Rate S. score 
CNS 
status 
Drugs 
given 
Remarks 
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Complications during CPAP :   
 
Date of application :                                      Date of weaning :                                                
 
Post weaning  status :       normal / cpap /reintubation / stridor / other  
complications 
 
Outcome  :  
 
